2-128091383-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020120.4(UGGT1):c.26G>T(p.Gly9Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000508 in 1,576,196 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020120.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UGGT1 | ENST00000259253.11 | c.26G>T | p.Gly9Val | missense_variant | 1/41 | 1 | NM_020120.4 | ENSP00000259253.6 | ||
UGGT1 | ENST00000376723.7 | n.26G>T | non_coding_transcript_exon_variant | 1/41 | 1 | ENSP00000365913.3 | ||||
UGGT1 | ENST00000438277.5 | n.25+1G>T | splice_donor_variant, intron_variant | 1 | ENSP00000392701.1 | |||||
UGGT1 | ENST00000430075.5 | n.25+1G>T | splice_donor_variant, intron_variant | 4 | ENSP00000400426.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152248Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000265 AC: 5AN: 188830Hom.: 0 AF XY: 0.0000396 AC XY: 4AN XY: 101052
GnomAD4 exome AF: 0.00000492 AC: 7AN: 1423948Hom.: 0 Cov.: 29 AF XY: 0.00000568 AC XY: 4AN XY: 704660
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152248Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 12, 2023 | The c.26G>T (p.G9V) alteration is located in exon 1 (coding exon 1) of the UGGT1 gene. This alteration results from a G to T substitution at nucleotide position 26, causing the glycine (G) at amino acid position 9 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at